|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7076 | |
| A61K 38/21 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2263678 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10182676.6 |
| Europos patento paraiškos padavimo data | 2005-12-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-12-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-06-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 638669 P | 2004-12-22 | US | |
| 04106909 | 2004-12-22 | EP |
| (72) |
De Luca, Giampiero, CH
Ythier, Arnaud, CH
Munafo, Alain, CH
Lopez-Bresnahan, Maria, US
|
| (73) |
Merck Serono SA,
Centre Industriel, 1267 Coinsins, Vaud,
CH
|
| (54) | Cladribine regimen for treating early secondary progressive Multiple Sclerosis |
| Cladribine regimen for treating early secondary progressive Multiple Sclerosis |